Santhera Pharmaceuticals Holding (SPHDF) Q4 2024 Earnings Report
SPHDF Q4 2024 EPS Results
- Actual EPS
- -$0.89
- Consensus EPS
- -$0.89
- Beat/Miss
- Met expectations
- One Year Ago EPS
- $8.75
SPHDF Q4 2024 Revenue Results
- Actual Revenue
- $30.10M
- Expected Revenue
- $10.83M
- Beat/Miss
- Beat by +$19.26M
- YoY Revenue Growth
- -74.87%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 04/29/2025
- Time
- Before Open
- Conference Call
- Tuesday, April 29, 2025
SPHDF Upcoming Earnings
Santhera Pharmaceuticals Holding's next earnings date is estimated for April 29, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
SPHDF Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
SPHDF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Apr 29, 2027 | 2026 (Q4) | ―- | -0.52 | ― | ― |
| Sep 30, 2026 | 2026 (Q2) | 0.20-1.81 | -0.45 | -305.41% (-1.36) | |
| Apr 28, 2026 | 2025 (Q4) | -0.52-0.52 | -0.89 | 41.89% (+0.37) | |
| Sep 23, 2025 | 2025 (Q2) | -0.72-3.66 | -1.63 | -125.19% (-2.03) | |
| Apr 29, 2025 | 2024 (Q4) | -0.89-0.89 | 8.75 | -110.18% (-9.64) | |
| Sep 12, 2024 | 2024 (Q2) | -1.13-1.63 | -1.9 | 14.56% (+0.28) | |
| Apr 25, 2024 | 2023 (Q4) | ―8.75 | -2.56 | 441.31% (+11.32) | |
| Sep 07, 2023 | 2023 (Q2) | -1.90-1.90 | -6.31 | 69.85% (+4.41) | |
| Apr 27, 2023 | 2022 (Q4) | ―-2.56 | -2.77 | 7.39% (+0.20) | |
| Oct 31, 2022 | 2022 (Q2) | ―-6.31 | -11.1 | 43.19% (+4.80) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed